Curet Myriam - Apr 21, 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Donna Spinola For: Curet, Myriam
Stock symbol
ISRG
Transactions as of
Apr 21, 2023
Transactions value $
-$1,505,793
Form type
4
Date filed
4/24/2023, 05:08 PM
Previous filing
Mar 1, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $333K +2K +102.56% $166.62 3.95K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$600K -2K -50.63% $300.00 1.95K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Options Exercise $1.05M +6K +307.69% $174.26 7.95K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$1.8M -6K -75.47% $300.00 1.95K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$333K -1.12K -57.33% $297.92 832 Apr 21, 2023 Direct F1, F2
transaction ISRG Common Stock Sale -$152K -505 -60.7% $300.00 327 Apr 21, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2K -30.77% $0.00 4.5K Apr 21, 2023 Common Stock 2K $166.62 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -6K -100% $0.00* 0 Apr 21, 2023 Common Stock 6K $174.26 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 10, 2023.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.54 to $299.27 as follows: 232 shares sold at $296.54 - $297.32; 666 shares sold at $297.57 - $298.50; 220 shares sold at $298.62 - $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.